We're #hiring a new Associate Director, Epidemiology in United States. Apply today or share this post with your network.
N-Power Medicine, Inc.
生物技术研究
Redwood City,California 1,988 位关注者
Accelerating Oncology Innovation
关于我们
N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors. The N-Power Platform consists of: - The real-time Kaleido? Registry, conducted with patient consent, that defines standardized data collection at the point of care and is malleable to partner needs, - A technology solution that enables data collection and analysis, and - Embedded on-site and virtual staff who support delivery of routine care, implement standardized, registry protocol-defined data collection and augment site staff in clinical research. By partnering with oncologists, research staff and patients in unlocking the full potential of every patient’s data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development.
- 网站
-
https://www.npowermedicine.com/
N-Power Medicine, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Redwood City,California
- 类型
- 私人持股
- 创立
- 2021
- 领域
- Clinical Trials、Oncology 、Drug Development和Real Time Registry
地点
-
主要
2221 Broadway St
US,California,Redwood City,94063
N-Power Medicine, Inc.员工
动态
-
We recently sat down with our colleague, Anna (Ania) Schwarzbach, Head of Medical Affairs, to discuss how we at N-Power Medicine are transforming oncology care and research. Ania emphasized the challenges oncology practices face in conducting research, including limited resources, time, and infrastructure, and highlighted how N-Power addresses these issues by seamlessly integrating routine care with clinical research. Through our Kaleido? Registry, AI-aided technology, and expert staffing support, we simplify data collection, reduce physician workload, and expand access to clinical trials, unlocking access to research for every patient. With nearly 50 MDs, and 10,000+ patients enrolled, and multiple studies launched, Ania’s leadership has been pivotal in building our growing network of community practices. Together, we’re proving that research and routine care can seamlessly coexist, shaping a more accessible and innovative future for cancer care. New Mexico Cancer Center- New Mexico Oncology Hematology Consultants, LTD, Northwest Oncology & Hematology, Oncology Consultants, Pacific Cancer Care #OncologyInnovation #ClinicalTrials #CancerResearch
-
?? SCOPE 2025 is less than a week away! A few members of our team, Mark Lee, Michael Seiden MD, PhD, Will Chen and Sydnie Reed, will be attending and would love to see you there. Come chat with us about how we're accelerating oncology clinical development by reinventing the how. #SCOPE2025 #ClinicalOps
-
-
?? Have a background in medical documentation and oncology? Join our team! #job #career #biotechjob #oncology Go here to learn more and apply: https://lnkd.in/g_npTRPn
-
-
?? ???We’re excited to announce that N-Power has acquired Syapse, a pioneer in precision medicine solutions for community cancer systems. The acquisition underscores N-Power’s commitment to dramatically accelerate drug development and improve the probability of success of trials by seamlessly integrating clinical research into every oncologist’s practice and every cancer patient’s care. Read more about our acquisition here: https://lnkd.in/g99sxxXa #ClinicalTrials #CancerResearch?#Oncology #CancerInnovation #Acquisition
-
? Happy Holidays from N-Power! ? As we wrap up a truly incredible year, we want to take a moment to express our heartfelt gratitude to all who make what we do possible. To our amazing team: Thank you for your dedication, passion, and unwavering commitment to excellence. You’ve helped us achieve so much this year, and we couldn’t be prouder of what we’ve accomplished together. To our valued partners: Your trust and collaboration continue to inspire us. We’re deeply honored to work alongside you to support our shared mission of expanding access to clinical trials for patients. As we celebrate this holiday season, let’s look forward to 2025 with renewed energy, purpose, and a commitment to making an even greater impact. Wishing you and your loved ones a joyful, peaceful, and safe holiday season!
-
N-Power Medicine is proud to collaborate with our Network Partners — New Mexico Cancer Center- New Mexico Oncology Hematology Consultants, LTD, Northwest Oncology & Hematology, Oncology Consultants, and Pacific Cancer Care? — in sharing a mission to effectively and efficiently bridge routine care and clinical research within community oncology practices. Together, we’re creating a seamless operating model that empowers physicians and patients everywhere to access innovative new medicines through clinical trials and participate in clinical research. In this video, see what Dr. Campos and Dr. Peguero at Oncology Consultants have to say about working with N-Power Medicine. ?? ?? Uniting Workflows for Better Outcomes At N-Power Medicine, our mission is to unite workflows across routine care and clinical research to expand access to clinical trials and serve the unique needs of community oncology. By leveraging our proprietary platform, we’re helping practices collect standardized, research-ready data during routine care—without increasing physician workload. ?? Why This Matters: As Dr. Campos emphasized, “Timing is crucial because a patient won’t wait—they need immediate plans”. With our integrated Kaleido Registry and streamlined processes, we’re making it possible for oncologists to systematically identify trial patients at the right time in their journeys while simultaneously reducing overall physician administrative burden, and deliver research treatment opportunities closer to the homes of patients. ?? Key Impacts of Our Collaboration: Empowering Physicians: Enabling oncologists to seamlessly adopt clinical research into their practice without disrupting routine care. Expanding Patient Access: Streamlining patient enrollment ensures more patients can participate in clinical trials. Advancing Drug Development: Unlocking the full potential of every patient’s data provides unprecedented insights for biopharmaceutical innovation. ?? A Shared Vision This partnership reflects our commitment to fostering a culture of research in community oncology. Together, N-Power Medicine and its Network Partners are breaking down barriers to clinical research, ensuring every patient has access to cutting-edge care and every community practice can contribute to advancing medicine. The future of oncology is here, and it’s happening where it’s needed most—in the communities we serve. #NPowerMedicine #NMOHC #NorthwestOncologyHematology #OncologyConsultants? #PacificCancerCare #OncologyConsultants #CommunityOncology #ClinicalResearch
-
We are thrilled to announce that Michael Seiden MD, PhD, has joined N-Power as our new Chief Medical Officer and Head of Network Services! Please join us in giving him a warm welcome to the team ??
?? Exciting News for N-Power Medicine, Inc.! We are delighted to welcome Michael Seiden MD, PhD as our new Chief Medical Officer and Head of Network Services. Michael is a distinguished leader in oncology care and research in both the academic and community settings, most?recently serving as President of the US Oncology Network, and?previously, CEO and President of Fox Chase Cancer Center.? Earlier in his career, Michael served as Chief of Clinical and Translational Cancer Research at MGH.? Michael’s extensive expertise in research and community-based clinical care, combined with his exceptional leadership, will be instrumental in expanding the N-Power Network of community oncology practices and advancing our mission to make clinical research a part of every oncologist’s practice and every cancer patient’s care. Please join us in welcoming Michael to N-Power Medicine! ????? #Welcome #Leadership #Oncology #ClinicalResearch #TeamNPower
-
-
This Cancer Screen Week (12/2–12/6), let’s prioritize our health and the health of those we care about. Regular cancer screenings save lives by detecting issues early when treatment can be most effective. Yet, many people delay or skip screenings altogether. Learn more about Cancer Screen Week at https://lnkd.in/eRA4KZq #CancerScreenWeek #EarlyDetection #CancerAwareness #HealthForAll
-
-
?? New career alert! Join the NPM team as a Clinical Data Engineer. Apply here: https://lnkd.in/gXRaeTf5
-